RiverVest Venture Fund IV, L.P.
Related Filers (6)
- RiverVest Venture Fund III, L.P. (4)
- RiverVest Venture Fund III (Ohio), L.P. (4)
- Xilio Therapeutics, Inc. (3)
- Mirum Pharmaceuticals, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (2)
- Reneo Pharmaceuticals, Inc. (2)
- Show More ...
Other (2)
D/A
Tuesday, 10/9/2018
Exempt (Private) Offering
D
Thursday, 12/14/2017
Exempt (Private) Offering
Ownership (10)
SC 13D/A
Thursday, 12/1/2022
Mirum Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Friday, 11/5/2021
Xilio Therapeutics, Inc.: Major Shareholders
4
Tuesday, 10/26/2021
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/21/2021
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 4/13/2021
Reneo Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/8/2021
Reneo Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 12/22/2020
Mirum Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 10/16/2020
SPRUCE BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/8/2020
SPRUCE BIOSCIENCES, INC.: Initial statement of beneficial ownership of securities
SC 13D
Thursday, 8/1/2019
Mirum Pharmaceuticals, Inc.: Major Shareholders